Additional file 1 of Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial
article
OA: green
CC0
AI-generated summary
This randomized clinical trial investigated the efficacy of anastrozole and a levonorgestrel-releasing intrauterine device for treating endometriosis, presenting results in a table of clinical publications on aromatase inhibitors for this condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Additional file 1: Table S1. Clinical publications on the use of Aromatase Inhibitors in women with endometriosis. CPP, chronic pelvic pain; VAS, visual analogue scale; OCP, oral contraceptive pill.
My notes (saved in your browser only)
Outcome instruments
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Aromatase expression in endometriosis. via openalex
- Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings via openalex
- Aromatase Inhibitors for Endometriosis-Associated Infertility; Do We Have Sufficient Evidence? via openalex
- Aromatase inhibitors for the treatment of endometriosis via openalex
- Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
- Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside via openalex
- Committee Opinion No. 663 via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> via openalex
- Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis via openalex
- Full-Thickness Excision versus Shaving by Laparoscopy for Intestinal Deep Infiltrating Endometriosis: Rationale and Potential Treatment Options via openalex
- GnRH Analogues, Transvaginal Ultrasound-Guided Drainage and Intracystic Injection of Recombinant Interleukin-2 in the Treatment of Endometriosis via openalex
- Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression via openalex
- Letrozole and desogestrel‐only contraceptive pill for the treatment of stage IV endometriosis via openalex
- Letrozole and norethisterone acetate in colorectal endometriosis via openalex
- Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex
- Neuroendocrine–immune disequilibrium and endometriosis: an interdisciplinary approach via openalex
- Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain via openalex
- Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study via openalex
- Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study via openalex
- Progesterone Resistance in Endometriosis: an Acquired Property? via openalex
- Progesterone resistance in endometriosis: origins, consequences and interventions via openalex
- Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex
- Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients via openalex
- The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
- The efficacy of long‐term maintenance therapy with a levonorgestrel‐releasing intrauterine system for prevention of ovarian endometrioma recurrence via openalex
- The emerging use of aromatase inhibitors for endometriosis treatment via openalex
- The levonorgestrel-releasing intrauterine system and endometriosis staging via openalex
- The levonorgestrel‐releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in <scp>CA</scp> 125 levels, and an increase in quality of life in women with suspected endometriosis via openalex
- The pathophysiology of endometriosis and adenomyosis: tissue injury and repair via openalex
- Treatment of Endometriosis with Transvaginal Ultrasound-Guided Drainage and Recombinant Interleukin-2 Left in the Cysts: A Third Clinical Trial via openalex
- Treatment of Endometriosis with Transvaginal Ultrasound-Guided Drainage under GnRH Analogues and Recombinant Interleukin-2 Left in the Cysts via openalex
- Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
- (no identifier) via openalex
Source provenance
- openalex
- last seen: 2026-05-13T18:33:16.088889+00:00
License: CC0
· commercial use OK